Table 3.
Additional participant demographicsa
| Code | Gender | Mental Illness/es referred to | Duration of medication use |
|---|---|---|---|
| P1 | F | anxiety, depression, OCD | approx. 2.5 years |
| P2 | F | anxiety, depression, bipolar disorder, eating disorder | variable use over approx. 9 years |
| P3 | F | anxiety, depression | 11 months |
| P4 | F | not specifiedb | 6 months |
| P5 | F | anxiety, depression | 12 months |
| P6 | F | depression | not reported |
| P7 | F | anxiety | approx. 3 months |
| P8 | M | anxiety, depression | current medication 4 months, trialled other medication previously |
| P9 | F | not specifiedc | nearly 3 years |
| P10 | F | depression | 1.5 years |
| P11 | F | anxiety, depression | current medication 7–8 months, trialled other medication previously |
| P12 | F | anxiety, depression | variable use over 2 years |
| P13 | M | bipolar disorder | not reported but mentioned using one medication for at least 12 months |
| P14 | F | depression | approx. 6 years |
| P15 | F | anxiety, depression | 2–3 years |
| P16 | F | Anxiety, depression | not reported |
| P17 | F | PTSD/anxiety, depression | 11 months |
| P18 | F | Anxiety, depression, eating disorder | approx. 2 years |
a Details were deciphered from interview data only and must not be taken as complete information
b Participant thought they did not have depression but bipolar disorder
c Participant referred to a medicine that was used when needed for a panic attack/anxiety